Research

New zebrafish model offers new insights into skin cancer

Scientists in the UK and Switzerland have identified a signalling pathway, PI3K (phosphoinositide 3-kinase) that shows promise as a target for treating aggressive skin cancer. Their results, based on a study of the see-through zebrafish, are published in the journal Disease Models and Mechanisms.

Sharing the Sights of BioMedical and Pharmaceutical Domains on Demo-DVD

CAST PHARMA, a premier European 3D pharmaceutical and biomedical animation production company, is pleased to announce the availability of an advanced Demo-DVD to make its audiovisual material more widely available to the existing and further customers from the biomedical and pharmaceutical domains.

BMJ Group Produces Authoritative Guide And Courses On Swine Flu For Medical Professionals Across The World

Responding to the World Health Organisation's recent confirmation of swine flu as a pandemic, BMJ Learning, the medical education arm of the BMJ Group, has updated and revised its guide 'Influenza pandemics: why, what, and how to prepare' which covers all the information doctors need to know about pandemic flu including details of the epidemiological features and a description of the viruses involved.

Information Technology Award announced for pharmacy in 2010

First DataBank Europe (FDBE) is pleased to announce, in association with The Guild of Healthcare Pharmacists (GHP) and the UK Clinical Pharmacy Association (UKCPA), the 2010 FDBE/GHP/UKCPA Information Technology Award.

BBMRI - Biobanking and Biomolecular Resources Research Infrastructure

The Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) was set up in 2008 to coordinate a large scale network to share access to available biological samples in Europe. This infrastructure will cover major biobanks, molecular resources and biocomputing centres to ensure that the samples are linked to existing databases, scientific literature and statistical expertise.

Regular aspirin use may do more harm than good, study warns

Can an aspirin a day keep the doctor away? New research, part of the EU-funded BIOMED (Biomedicine and health) programme, shows it can't all the time. The researchers have discovered that although regular use of aspirin can reduce the rate of non-fatal heart attacks or stroke by around 12%, there is a 33% increase in the risk of internal bleeding in people with no history of relevant disease (primary prevention). The findings are published in The Lancet journal.

From Pioneer to the World's Leading Scientific Network

"Pioneers" was the headline when Science magazine covered the launch of the academic networking platform ResearchGATE exactly one year ago. In a very short time, a small group of pioneers in scientific communication, located at Harvard University and Hannover Medical School (Germany), has managed to create a worldwide community with more than 50,000 members from 196 countries.

Research & Development

New zebrafish model offers new insights into skin cancer

Sharing the Sights of BioMedical and Pharmaceutical Domains on Demo-DVD

BMJ Group Produces Authoritative Guide And Courses On Swine Flu For Medical Professionals Across The World

Information Technology Award announced for pharmacy in 2010

BBMRI - Biobanking and Biomolecular Resources Research Infrastructure

Regular aspirin use may do more harm than good, study warns

From Pioneer to the World's Leading Scientific Network

More Pharma News ...